Literature DB >> 9860953

Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor.

C C Lai1, C Henningson, D DiMaio.   

Abstract

The bovine papillomavirus E5 protein is a 44-aa transmembrane protein that forms a stable complex with the cellular platelet-derived growth factor (PDGF) beta receptor and induces constitutive tyrosine phosphorylation and activation of the receptor, resulting in cell transformation. The E5 protein does not resemble PDGF, but rather activates the receptor in a ligand-independent fashion, thus providing a unique system to examine activation of receptor tyrosine kinases. Here, we used a variety of approaches to explore the mechanism of receptor activation by the E5 protein. Chemical cross-linking experiments revealed that the E5 protein activated only a small fraction of the endogenous PDGF beta receptor in transformed fibroblasts and suggested that this fraction was constitutively dimerized. Coimmunoprecipitation experiments using extracts of cells engineered to coexpress full-length and truncated PDGF beta receptors confirmed that the E5 protein induced oligomerization of the receptor. Furthermore, in cells expressing the E5 protein, a kinase-active receptor was able to trans-phosphorylate a kinase-negative mutant receptor but was unable to catalyze intramolecular autophosphorylation. These results indicated that the E5 protein induced PDGF beta receptor activation by forming a stable complex with the receptor, resulting in receptor dimerization and trans-phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860953      PMCID: PMC28027          DOI: 10.1073/pnas.95.26.15241

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.

Authors:  L A Nilson; R L Gottlieb; G W Polack; D DiMaio
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

2.  Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.

Authors:  M Mohammadi; J Schlessinger; S R Hubbard
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

Review 3.  Autoregulatory mechanisms in protein-tyrosine kinases.

Authors:  S R Hubbard; M Mohammadi; J Schlessinger
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

4.  Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.

Authors:  L M Petti; V Reddy; S O Smith; D DiMaio
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 5.  Platelet-derived growth factor receptor signals.

Authors:  L Claesson-Welsh
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

6.  Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.

Authors:  D Drummond-Barbosa; R R Vaillancourt; A Kazlauskas; D DiMaio
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.

Authors:  D J Riese; D DiMaio
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

Review 8.  Dimerization of cell surface receptors in signal transduction.

Authors:  C H Heldin
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.

Authors:  J Sparkowski; M Mense; J Anders; R Schlegel
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.

Authors:  A Staebler; J H Pierce; S Brazinski; M A Heidaran; W Li; R Schlegel; D J Goldstein
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more
  28 in total

1.  Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells.

Authors:  F Bussolino; G Serini; S Mitola; G Bazzoni; E Dejana
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

2.  Construction and maintenance of randomized retroviral expression libraries for transmembrane protein engineering.

Authors:  Sara A Marlatt; Yong Kong; Tobin J Cammett; Gregory Korbel; James P Noonan; Daniel Dimaio
Journal:  Protein Eng Des Sel       Date:  2010-12-10       Impact factor: 1.650

3.  Biologically active LIL proteins built with minimal chemical diversity.

Authors:  Erin N Heim; Jez L Marston; Ross S Federman; Anne P B Edwards; Alexander G Karabadzhak; Lisa M Petti; Donald M Engelman; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-10       Impact factor: 11.205

4.  Productive interaction between transmembrane mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor.

Authors:  Char-Chang Lai; Anne P B Edwards; Daniel DiMaio
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Packing contacts can mediate highly specific interactions between artificial transmembrane proteins and the PDGFbeta receptor.

Authors:  Jennifer B Ptacek; Anne P B Edwards; Lisa L Freeman-Cook; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

6.  A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.

Authors:  Lisa M Petti; Kristina Talbert-Slagle; Megan L Hochstrasser; Daniel DiMaio
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

7.  Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction.

Authors:  Anne P B Edwards; Yanhua Xie; Lara Bowers; Daniel DiMaio
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

8.  Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor.

Authors:  Kristina Talbert-Slagle; Sara Marlatt; Francisco N Barrera; Ekta Khurana; Joanne Oates; Mark Gerstein; Donald M Engelman; Ann M Dixon; Daniel Dimaio
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 9.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.

Authors:  Kristina Talbert-Slagle; Daniel DiMaio
Journal:  Virology       Date:  2008-11-06       Impact factor: 3.616

10.  In vitro dimerization of the bovine papillomavirus E5 protein transmembrane domain.

Authors:  Joanne Oates; Matthew Hicks; Timothy R Dafforn; Daniel DiMaio; Ann M Dixon
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.